ID theft scheme results in 7,300 breach notifications at Emory

The Atlanta-based Emory Healthcare was recently informed that information from 32 patients treated in the Emory Clinic section of orthopedics was found in the possession of a non-Emory-affiliated individual.

According to Duluth, Ga., police investigators, the individual was involved in an identity theft scheme and has been charged and pled guilty to ID theft with the intent of filing fraudulent tax returns, according to a breach notification letter which was sent to more than 7,300 patients that may have had clinical encounters around the same time with the section of orthopedics.

The documents found included patient information sheets containing names, dates of birth and social security numbers. However, Emory Healthcare stated it has no reason to believe any of the 7,300 individuals have been impacted in any way.

Emory found through its own internal investigation that five items found in the possession of the charged individual were printed by another person, who was an employee of Emory Healthcare. Because the employee was printing this information outside the scope of specified duties, this action was deemed to place patient information at risk, and violated Emory’s standards to strictly monitor and safeguard confidential patient information.

“This issue is in no way a breach of Emory’s EMR system, but rather a human failure to properly follow Emory Healthcare’s prescribed duties and responsibilities for protecting private patient information,” the letter stated. “Our more than 14,000 employees, faculty and staff are briefed regularly upon hire and throughout employment on the importance of safeguarding sensitive information - and the severe consequences for failure to properly adhere to these principles.”

Emory stated it has also implemented additional steps to better protect the confidentiality of all patient information.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.